Tag Archives: Biomarkers

Collaboration will demonstrate the powerful advantages of transcriptomic data analysis for prediction of the response to novel cancer therapies

rna-seq

BostonGene Corporation, a biomedical software company committed to defining optimal precision medicine-based therapies for cancer patients, today announced a scientific collaboration with Brigham and Women’s Hospital, a world-class academic medical center and a major teaching hospital of Harvard Medical School ...

Read More »

An RNA-Seq Primer

rna-seq

Pharmacogenomics has revealed compelling genetic signals associated with variability in drug response. Gene expression studies represent an additional approach to identify candidate genes accounting for drug response variability. Researchers from the University of Florida discuss insights that might be gained through analysis of ...

Read More »